Atossa Therapeutics
ATOS
#10757
Rank
โ‚น1.80 B
Marketcap
โ‚น180.38
Share price
-1.53%
Change (1 day)
157.47%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -โ‚น3.46 Billion

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น3.25 Billion a decrease over its 2024 earnings that were of -โ‚น2.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น3.46 Billion6.36%
2025 -โ‚น3.25 Billion36.33%
2024 -โ‚น2.39 Billion-15.25%
2023 -โ‚น2.82 Billion11.62%
2022 -โ‚น2.52 Billion30.84%
2021 -โ‚น1.93 Billion15.58%
2020 -โ‚น1.67 Billion3.41%
2019 -โ‚น1.62 Billion51.16%
2018 -โ‚น1.07 Billion40.41%
2017 -โ‚น0.76 Billion27.54%
2016 -โ‚น0.6 Billion-47.49%
2015 -โ‚น1.14 Billion-17.25%
2014 -โ‚น1.37 Billion35.91%
2013 -โ‚น1.01 Billion112.3%
2012 -โ‚น0.48 Billion46.53%
2011 -โ‚น0.33 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.749 T-49,745.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น139.44 B-4,056.62%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น135.98 B-3,958.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น3.89 B-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น3.08 Billion-12.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น0.74 Billion-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA